AU2001264376A1 - Urea derivative useful as an anti-cancer agent and process for preparing same - Google Patents

Urea derivative useful as an anti-cancer agent and process for preparing same

Info

Publication number: AU2001264376A1
Authority: AU; Australia
Prior art keywords: cancer agent; urea derivative; preparing same; derivative useful; useful
Prior art date: 2000-06-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Chaconne Nsi Co Ltd

Original Assignee

Chaconne Nsi Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-13Application filed by Chaconne Nsi Co LtdfiledCriticalChaconne Nsi Co Ltd

2001-12-24Publication of AU2001264376A1publicationCriticalpatent/AU2001264376A1/en

StatusAbandonedlegal-statusCriticalCurrent

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
- C07D253/10—Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AU2001264376A2000-06-152001-06-13Urea derivative useful as an anti-cancer agent and process for preparing sameAbandonedAU2001264376A1 (en)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
KR20000032927		2000-06-15
KR20000032930		2000-06-15
KR0032930		2000-06-15
KR0032925		2000-06-15
KR20000032925		2000-06-15
KR0032927		2000-06-15
KR0045427		2000-08-05
KR20000045427		2000-08-05
PCT/KR2001/001017WO2001095856A2 (en)	2000-06-15	2001-06-13	Urea derivative useful as an anti-cancer agent and process for preparing same

Publications (1)

Publication Number	Publication Date
AU2001264376A1true AU2001264376A1 (en)	2001-12-24

Family

ID=27483460

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001264376AAbandonedAU2001264376A1 (en)	2000-06-15	2001-06-13	Urea derivative useful as an anti-cancer agent and process for preparing same

Country Status (3)

Country	Link
US (1)	US20020019389A1 (en)
AU (1)	AU2001264376A1 (en)
WO (1)	WO2001095856A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0116113A (en)	2000-12-12	2004-08-03	Neurogen Corp	Spiro [isobenzofuran-1,4'-piperidin] -3-ones and 3h-spiroisoben-zofuran-1,4'-piperidines
EP1695977A3 (en)*	2000-12-12	2006-09-20	Neurogen Corporation	Spiro [isobenzofuran-1,4'piperidin]-3-ones and 3H-spiroisobenzofuran-1, 4'-piperidines
MXPA04005151A (en)*	2001-11-28	2004-08-11	Upjohn Co	Therapeutic compounds.
US7449480B2 (en)	2002-05-14	2008-11-11	Baylor College Of Medicine	Small molecule inhibitors of HER2 expression
EP1509226A4 (en)*	2002-05-14	2008-04-09	Baylor College Medicine	SMALL INHIBITORY MOLECULES OF HER2 GENE EXPRESSION
JP4621502B2 (en)	2002-06-28	2011-01-26	ユーロ−セルティークエス．エイ．	A therapeutic agent useful for the treatment of pain
US7262194B2 (en)*	2002-07-26	2007-08-28	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
EP1527774A1 (en)	2003-11-03	2005-05-04	Basilea Pharmaceutica AG	New formulation for retinoid-containing soft gelatin capsules
KR100977242B1 (en)*	2003-07-24	2010-08-24	유로-셀띠끄 소시에떼 아노님	Piperidine Compounds and Pharmaceutical Compositions Comprising the Same
JP2008511552A (en)	2004-08-30	2008-04-17	ニューロメッドファーマシューティカルズリミテッド	Urea derivatives as calcium channel blockers
ATE499366T1 (en)	2004-11-17	2011-03-15	Rexahn Pharmaceuticals Inc	1-Ä(6-SUBSTITUTED ALKOXYCHINOXALINYL)
US7511077B2 (en)*	2005-02-09	2009-03-31	Neuromed Pharmaceuticals Ltd.	Diamine calcium channel blockers
CA2618653A1 (en)*	2005-08-12	2007-02-22	Takeda Pharmaceutical Company Limited	Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder
ME01308B (en)	2006-10-18	2013-12-20	Pfizer Prod Inc	Biaryl ether urea compounds
JO2972B1 (en)	2007-06-08	2016-03-15	جانسين فارماسوتيكا ان. في	Piperidine/Piperazine derivatives
CA2687918C (en)*	2007-06-08	2016-11-08	Janssen Pharmaceutica N.V.	Piperidine/piperazine derivatives
PA8783601A1 (en)	2007-06-08	2009-01-23	Janssen Pharmaceutica Nv	PIPERIDINE / PIPERAZINE DERIVATIVES
JP5443342B2 (en)	2007-06-08	2014-03-19	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Piperidine / piperazine derivatives
EP2262499B1 (en)*	2008-03-11	2016-12-21	University Health Network	Mk-0557 for use in the treatment of cancer
JP5579170B2 (en)	2008-06-05	2014-08-27	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Pharmaceutical combination comprising a DGAT inhibitor and a PPAR agonist
JP2019533022A (en)	2016-10-24	2019-11-14	ユマニティセラピューティクス，インコーポレーテッド	Compounds and uses thereof
CA3049010A1 (en)	2017-01-06	2018-07-12	Yumanity Therapeutics, Inc.	Methods for the treatment of neurological disorders
CN108299411B (en)*	2017-01-13	2021-02-05	中国人民解放军军事医学科学院毒物药物研究所	4, 4-diphenyl piperidine compound or pharmaceutically acceptable salt, pharmaceutical composition and application thereof
WO2019084157A1 (en)	2017-10-24	2019-05-02	Yumanity Therapeutics, Inc.	Compounds and uses thereof
MX2020009942A (en)	2018-03-23	2021-01-08	Yumanity Therapeutics Inc	Compounds and uses thereof.
US12098146B2 (en)	2019-01-24	2024-09-24	Janssen Pharmaceutica Nv	Compounds and uses thereof
WO2020182929A1 (en)*	2019-03-13	2020-09-17	Bayer Aktiengesellschaft	Substituted ureas and derivatives as new antifungal agents
CN110204504A (en)*	2019-04-18	2019-09-06	湖北大学	The more two thiocarbohydrazone derivatives of piperazines of triazine radical and its synthetic method and application
EA202192047A1 (en)	2019-11-13	2021-12-08	Юманити Терапьютикс, Инк.	COMPOUNDS AND THEIR APPLICATIONS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4073961B2 (en)*	1996-10-01	2008-04-09	協和醗酵工業株式会社	Nitrogen-containing heterocyclic compounds
US6040321A (en)*	1997-11-12	2000-03-21	Bristol-Myers Squibb Company	Aminothiazole inhibitors of cyclin dependent kinases
WO2000017163A1 (en)*	1998-09-22	2000-03-30	Yamanouchi Pharmaceutical Co., Ltd.	Cyanophenyl derivatives
US6531477B1 (en)*	1998-10-13	2003-03-11	Dupont Pharmaceuticals Company	6-substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
GB9823873D0 (en)*	1998-10-30	1998-12-30	Pharmacia & Upjohn Spa	2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents

2001
- 2001-06-13AUAU2001264376Apatent/AU2001264376A1/ennot_activeAbandoned
- 2001-06-13WOPCT/KR2001/001017patent/WO2001095856A2/enactiveApplication Filing
- 2001-06-14USUS09/880,823patent/US20020019389A1/ennot_activeAbandoned

Also Published As

Publication number	Publication date
WO2001095856A2 (en)	2001-12-20
WO2001095856A3 (en)	2002-06-27
US20020019389A1 (en)	2002-02-14

Publication	Publication Date	Title
AU2001264376A1 (en)	2001-12-24	Urea derivative useful as an anti-cancer agent and process for preparing same
HUP0201225A3 (en)	2003-11-28	4,5,6,7-tetrahydroindazole derivatives as antitumor agent and process for their preparation
AU2001236148A1 (en)	2001-08-27	Polyorganosilsesquioxane and process for preparing the same
HUP0202492A3 (en)	2004-12-28	Arylmethyl-carbonylamino-thiazole derivatives process for their preparation and their use as antitumor agents
IL175363A0 (en)	2006-09-05	Urea derivative and process for preparing the same
AU2002358700A1 (en)	2003-07-15	Urea derivatives as vr1- antagonists
GB9823873D0 (en)	1998-12-30	2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
HUP0303729A3 (en)	2009-01-28	Novel heteroaryl derivatives and the use thereof as pharmaceuticals and process for their preparation
AU2002233463A1 (en)	2002-08-06	Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use
AU2001269198A1 (en)	2002-01-02	Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
IL159570A0 (en)	2004-06-01	Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
AU6646400A (en)	2001-03-26	System and method for producing folded articles
AU6783700A (en)	2001-03-26	System and method for producing folded articles
AU5426500A (en)	2001-01-02	Benzazepine derivatives, process for the preparation of the same and uses thereof
AU7972200A (en)	2001-05-08	Process for the preparation of urea
AU2466700A (en)	2000-08-07	Process for the preparation of urea
AU6442900A (en)	2001-03-19	Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
AU7446900A (en)	2001-04-30	Thioalkylamine derivatives and process for the preparation thereof
AU6866500A (en)	2001-03-26	Chromone derivatives, process for the preparation of the same and uses thereof
AU2000254308A1 (en)	2001-11-26	Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU2001293907A1 (en)	2002-03-26	Method for preparing camptothecin and its derivatives
AU2002227966A1 (en)	2002-08-22	Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2001252671A1 (en)	2001-11-20	Pyridobenzodiazine derivatives and processes for the preparation thereof
HUP0001218A3 (en)	2003-02-28	Methods of isolating urea, urea compositions and methods for producing the same
AU2002222604A1 (en)	2002-08-29	Process for preparing substance GM-95

Legal Events

Date	Code	Title	Description
2002-05-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
2002-05-23	TH	Corrigenda	Free format text:IN VOL 16, NO 12, PAGE(S) 2688-2711 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 47847/00, 54308/00, 58034/01, 62758/01, 64350/01, 64351/01, 64371/01, 64376/01, 64379/01, 64380/01, 64381/01, 64387/01, 66120/01, 66366/01, 66367/01, 66382/01, 66397/01, 69195/01, 69211/01, 70381/01, 74633/01, 74647/01, 74651/01, 78369/01, 78369/01, 80265/01, 80266/01, 82687/01, 83818/01, 89304/01, 15608/02

Movatterモバイル変換

AU2001264376A1 - Urea derivative useful as an anti-cancer agent and process for preparing same - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (9)

Publications (1)

Family

ID=27483460

Family Applications (1)

Country Status (3)

Families Citing this family (29)

Family Cites Families (5)

Also Published As

Similar Documents

Legal Events